TheraVida, Inc.

Technology

TheraVida has developed a novel combination drug platform, whereby a secondary agent is added to a primary pharmaceutical ingredient, in order to reduce or eliminate problematic drug side effects for patients. TheraVida has tested its proprietary and patent-protected combination drug technology in multiple human clinical trials, with excellent results in terms of improved patient safety and side effects, better tolerability, and enhanced therapeutic efficacy.

This unique technology developed by TheraVida, involves the combination of positive-acting agents (or “agonists”) with negative-acting agents (or “antagonists”) into a single therapeutic product. In this way, TheraVida products are able to counter-act many of the undesirable or intolerable side effects experienced by patients on various medications, while preserving or even enhancing drug efficacy in the treatment of different disorders.

TheraVida combination drug technology not only has the potential to enhance the medical benefits for patients, but it also can result in potentially better patient satisfaction and improvements in long-term compliance.